KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $515.0 million.

  • Gilead Sciences' Change in Inventory rose 50588.24% to $515.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 12465.48%. This contributed to the annual value of $426.0 million for FY2024, which is 4940.62% down from last year.
  • Per Gilead Sciences' latest filing, its Change in Inventory stood at $515.0 million for Q3 2025, which was up 50588.24% from $175.0 million recorded in Q2 2025.
  • Gilead Sciences' Change in Inventory's 5-year high stood at $515.0 million during Q3 2025, with a 5-year trough of -$70.0 million in Q3 2021.
  • Over the past 5 years, Gilead Sciences' median Change in Inventory value was $85.0 million (recorded in 2024), while the average stood at $130.5 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 36923.08% in 2021, then soared by 292500.0% in 2023.
  • Gilead Sciences' Change in Inventory (Quarter) stood at -$35.0 million in 2021, then skyrocketed by 888.57% to $276.0 million in 2022, then rose by 11.23% to $307.0 million in 2023, then fell by 26.38% to $226.0 million in 2024, then soared by 127.88% to $515.0 million in 2025.
  • Its last three reported values are $515.0 million in Q3 2025, $175.0 million for Q2 2025, and $223.0 million during Q1 2025.